A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Metabolic Dysfunction-Associated Steatotic Liver Disease · Metabolic Dysfunction-Associated Steatohepatitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Arizona Liver Health, Chandler, Arizona, United States
Adobe Clinical Research, Tucson, Arizona, United States
Richmond Pharmacology Limited, London, Greater London, United Kingdom
Parexel International Early Phase Clinical Unit, Harrow, London, United Kingdom
Study leads
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals